<DOC>
	<DOC>NCT00902057</DOC>
	<brief_summary>To study, with a prospective randomised controlled design, whether the subcutaneous administration of the haemostatic drug desmopressin, may improve the impairment of primary haemostasis due to mildly decreased temperature.</brief_summary>
	<brief_title>Desmopressin for Bleeding Related to Low Body Temperature</brief_title>
	<detailed_description />
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>1. Healthy volunteers 1. Any known platelet or coagulation disorder. 2. Pregnant or lactating women. 3. Known chronic liver or renal disease. 4. Coronary artery, carotid artery or peripheral artery disease 5. Recent history of taking antiplatelet drugs, anticoagulants or herbal preparations. 6. Smoker or alcohol user 7. Mentally incapable of providing informed consent 8. Students or junior staff members who had direct working relationship with the PI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>